"My understanding is it approval runs out in August but SM1 don't expect an answer until end of year, maybe that deserves a market update."
Well, your understanding was incorrect. The new SAMR regulatory framework takes effect from 22 Feb 2023, and even then it only applies to product with a manufacturing date after that. Existing product can still be sold for the duration of its shelf life (which is 2 years).
"So now updates from other companies about your company is acceptable forms of company update, full of transparency and disclosure there."
I was just pointing to where I had seen the latest update on it, I was not making any comment on what you see as "acceptable" or not. Synalit is the company responsible for handling the re-registration process.
"I guess investing is about blind faith and reading between the lines and guessing at stock levels if your a rusted on a2m holder."
Well, I notice your sentiment is still "held" and has been for as long as I can remember. But no, everyone else is "rusted on", you're different
- Forums
- ASX - By Stock
- A2M
- FDA Approval
A2M
the a2 milk company limited
Add to My Watchlist
1.67%
!
$7.93

FDA Approval, page-174
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$7.93 |
Change
0.130(1.67%) |
Mkt cap ! $5.741B |
Open | High | Low | Value | Volume |
$7.87 | $7.99 | $7.71 | $17.74M | 2.261M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 111 | $7.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.96 | 3799 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400 | 7.710 |
4 | 5739 | 7.700 |
1 | 64 | 7.680 |
3 | 2750 | 7.670 |
1 | 500 | 7.660 |
Price($) | Vol. | No. |
---|---|---|
7.960 | 565 | 1 |
7.990 | 8000 | 1 |
8.000 | 6318 | 7 |
8.010 | 6039 | 2 |
8.020 | 3294 | 2 |
Last trade - 16.13pm 27/06/2025 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online